455 related articles for article (PubMed ID: 18284806)
21. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
Kafedjiiski K; Hoffer M; Werle M; Bernkop-Schnürch A
Biomaterials; 2006 Jan; 27(1):127-35. PubMed ID: 16045983
[TBL] [Abstract][Full Text] [Related]
22. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
23. Approaches for the development of solid and semi-solid lipid-based formulations.
Jannin V; Musakhanian J; Marchaud D
Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
[TBL] [Abstract][Full Text] [Related]
24. The potential of chitosan for the oral administration of peptides.
Prego C; Torres D; Alonso MJ
Expert Opin Drug Deliv; 2005 Sep; 2(5):843-54. PubMed ID: 16296782
[TBL] [Abstract][Full Text] [Related]
25. Thiomers: forms, functions and applications to nanomedicine.
Albrecht K; Bernkop-Schnürch A
Nanomedicine (Lond); 2007 Feb; 2(1):41-50. PubMed ID: 17716189
[TBL] [Abstract][Full Text] [Related]
26. Thiomers: promising platform for macromolecular drug delivery.
Laffleur F; Bernkop-Schnürch A
Future Med Chem; 2012 Nov; 4(17):2205-16. PubMed ID: 23190108
[TBL] [Abstract][Full Text] [Related]
27. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and in vitro evaluation of a novel thiolated chitosan.
Kafedjiiski K; Krauland AH; Hoffer MH; Bernkop-Schnürch A
Biomaterials; 2005 Mar; 26(7):819-26. PubMed ID: 15350788
[TBL] [Abstract][Full Text] [Related]
29. S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery.
Perrone M; Lopalco A; Lopedota A; Cutrignelli A; Laquintana V; Franco M; Bernkop-Schnürch A; Denora N
Eur J Pharm Biopharm; 2018 Nov; 132():103-111. PubMed ID: 30253185
[TBL] [Abstract][Full Text] [Related]
30. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
Sakloetsakun D; Iqbal J; Millotti G; Vetter A; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2011 Jun; 37(6):648-55. PubMed ID: 21561400
[TBL] [Abstract][Full Text] [Related]
31. S-protected thiolated chitosan: synthesis and in vitro characterization.
Dünnhaupt S; Barthelmes J; Thurner CC; Waldner C; Sakloetsakun D; Bernkop-Schnürch A
Carbohydr Polym; 2012 Oct; 90(2):765-72. PubMed ID: 22839999
[TBL] [Abstract][Full Text] [Related]
32. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
Föger F; Schmitz T; Bernkop-Schnürch A
Biomaterials; 2006 Aug; 27(23):4250-5. PubMed ID: 16618504
[TBL] [Abstract][Full Text] [Related]
33. Mucoadhesive properties and interaction with P-glycoprotein (P-gp) of thiolated-chitosans and -glycol chitosans and corresponding parent polymers: a comparative study.
Trapani A; Palazzo C; Contino M; Perrone MG; Cioffi N; Ditaranto N; Colabufo NA; Conese M; Trapani G; Puglisi G
Biomacromolecules; 2014 Mar; 15(3):882-93. PubMed ID: 24521085
[TBL] [Abstract][Full Text] [Related]
34. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
Fan B; Xing Y; Zheng Y; Sun C; Liang G
Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
[TBL] [Abstract][Full Text] [Related]
35. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
[TBL] [Abstract][Full Text] [Related]
36. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
[TBL] [Abstract][Full Text] [Related]
37. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation.
Roldo M; Hornof M; Caliceti P; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2004 Jan; 57(1):115-21. PubMed ID: 14729087
[TBL] [Abstract][Full Text] [Related]
38. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties.
Dünnhaupt S; Barthelmes J; Rahmat D; Leithner K; Thurner CC; Friedl H; Bernkop-Schnürch A
Mol Pharm; 2012 May; 9(5):1331-41. PubMed ID: 22489677
[TBL] [Abstract][Full Text] [Related]
39. Chitosan: a unique polysaccharide for drug delivery.
Felt O; Buri P; Gurny R
Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
[TBL] [Abstract][Full Text] [Related]
40. In vivo evaluation of thiolated chitosan tablets for oral insulin delivery.
Millotti G; Laffleur F; Perera G; Vigl C; Pickl K; Sinner F; Bernkop-Schnürch A
J Pharm Sci; 2014 Oct; 103(10):3165-70. PubMed ID: 25139279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
